Mepolizumab reduces moderate to severe COPD exacerbations in patients with varying blood eosinophil counts and type 2 ...
New research shows PPIs can limit fibrosis in eosinophilic oesophagitis, offering potential disease-modifying effects. Learn more about PPI therapy.
The FDA has accepted a Biologics License Application for imsidolimab to treat generalized pustular psoriasis, a rare inflammatory skin condition.
Children with food allergy who used omalizumab plus oral immunotherapy vs. omalizumab alone had similar rates of allergen ...
A brain-invading worm spread by rats and snails is making inroads into the United States. A study this week seems to show the ...
Raffle at Upcoming Islanders Game Will Support Eosinophilic Disease Research ATLANTA, GA, UNITED STATES, March 6, ...
Pediatric Rheumatologist Explains Many New Updates to ACR’s Juvenile Idiopathic Arthritis Guidelines
The new draft guidelines favor earlier DMARD therapy with ‘much decreased reliance on glucocorticoids that have several side effects in growing children,’ said rheumatologist Susan Shenoi, MS.
Recently published Chronic Rhinosinusitis with Nasal Polyps Market Insights report includes a comprehensive understanding of ...
Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.
PHILADELPHIA — The investigational drug verekitug improved sinonasal symptoms, reduced nasal polyp size, and reduced the need for nasal polyp surgery in people with chronic rhinosinusitis with nasal ...
A brain‑invading parasite better known as rat lungworm has quietly surfaced in San Diego County, turning up in wild animals ...
The FDA has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results